Cargando…
Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
Autores principales: | Gandy, Sam, Ehrlich, Michelle E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688142/ https://www.ncbi.nlm.nih.gov/pubmed/38037091 http://dx.doi.org/10.1186/s12974-023-02954-z |
Ejemplares similares
-
miR155, TREM2, INPP5D: Disease stage and cell type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
por: Gandy, Sam, et al.
Publicado: (2023) -
Alzheimer’s Amyloidopathy: An Alternative Aspect
por: Regland, Björn, et al.
Publicado: (2019) -
Oxidative stress: culprit or consequence in Alzheimer’s amyloidopathy
por: Sharma, Chanchal, et al.
Publicado: (2023) -
Microglial TYROBP/DAP12 in Alzheimer’s disease: Transduction of physiological and pathological signals across TREM2
por: Haure-Mirande, Jean-Vianney, et al.
Publicado: (2022) -
Microglial INPP5D limits plaque formation and glial
reactivity in the PSAPP mouse model of Alzheimer’s
disease
por: Castranio, Emilie L., et al.
Publicado: (2023)